Related Experiment Video
Updated: Aug 6, 2026

Analysis of Fucosylated Human Milk Trisaccharides in Biotechnological Context Using Genetically Encoded Biosensors
Published on: April 13, 2019
Plasmid- and Inducer-Free Biosynthesis of Difucosyllactose through Rational Fusion Enzyme Engineering and Systematic
Zhiqiang Liu1,2, Binglin Li1,2, Jieying Deng1,2
1Key Laboratory of Carbohydrate Chemistry and Biotechnology, Ministry of Education, Jiangnan University, Wuxi 214122, China.
Researchers developed a novel, plasmid- and inducer-free Escherichia coli strain for efficient difucosyllactose (DFL) production. This engineered strain significantly enhances DFL biosynthesis while minimizing intermediate accumulation, paving the way for cost-effective industrial applications.
Area of Science:
- Biotechnology and Metabolic Engineering
- Microbial Synthesis of Human Milk Oligosaccharides
Background:
- Difucosyllactose (DFL), a fucosylated human milk oligosaccharide, has significant industrial potential.
- Current microbial DFL production is hindered by intermediate (2'-FL) accumulation and high costs from antibiotics/inducers.
Purpose of the Study:
- To engineer a plasmid- and inducer-free Escherichia coli strain for enhanced DFL biosynthesis.
- To minimize 2'-fucosyllactose (2'-FL) accumulation during DFL production.
Main Methods:
- Established the de novo DFL pathway using various α-1,3-fucosyltransferases (α-1,3-FucT).
- Employed combinatorial metabolic engineering and the iMARS framework for enzyme design (FucTaY218K-L60-FutC).
- Engineered a beneficial mutant (FucTaY218K/W31R) and modified the lactose operon for improved growth and production.
Main Results:
- Achieved a DFL titer of 74 g/L with a productivity of 0.96 g/L/h in a 5-L bioreactor.
- Demonstrated the highest reported DFL productivity to date.
- Successfully minimized 2'-FL accumulation through rational enzyme engineering.
Conclusions:
- Developed a robust, environmentally friendly platform for industrial-scale DFL production.
- The study provides a viable strategy for microbial synthesis of other valuable human milk oligosaccharides.
Related Concept Videos
Bioreactor Controls-III
Production of Pharmaceuticals
Inducible Operons: lac Operon
Upstream Processing

